NCT03307902View on ClinicalTrials.gov

ID HBV Vaccination With Imiquimod in OBI

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

July 31, 2019

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Imiquimod + ID HBVv

Imiquimod ointment + intradermal 10μg Sci-B-Vac vaccine

BIOLOGICAL

Aqueous + ID HBVv

Aqueous ointment + intradermal 10μg Sci-B-Vac vaccine

BIOLOGICAL

Imiquimod + IM HBVv

Imiquimod ointment + intramuscular 10μg Sci-B-Vac vaccine

Trial Locations (1)

Unknown

University of Hong Kong, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT03307902 - ID HBV Vaccination With Imiquimod in OBI | Biotech Hunter | Biotech Hunter